| DRUG WATCH |
|
| Year : 2017 | Volume
: 49
| Issue : 1 | Page : 132-134 |
Hydroxychloroquine-induced erythroderma
Sunil B Pai1, Bhuvaneshwari Sudershan1, Maria Kuruvilla2, Ashwin Kamath1, Pooja K Suresh3
1 Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India
2 Department of Dermatology, Kasturba Medical College Hospital, Manipal University, Mangalore, Karnataka, India
3 Department of Pathology, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India
Correspondence Address:
Ashwin Kamath
Department of Pharmacology, Kasturba Medical College, Manipal University, Mangalore, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.201027
Erythroderma is characterized by diffuse erythema and scaling of the skin involving more than 90% of the total body skin surface area. Drug-induced erythroderma has rarely been reported with hydroxychloroquine. We report a case of a 50-year-old female patient, with systemic lupus erythematosus, who developed itchy lesions all over the body 1 month after starting treatment with hydroxychloroquine. Drug-induced erythroderma was suspected. Hydroxychloroquine was withdrawn and the patient was treated with emollients, mid-potency corticosteroids, and oral antihistamines. A biopsy was done which confirmed the diagnosis of erythroderma. She recovered with treatment and was discharged. A careful history and clinical examination to search for potential causative factors will help prevent disabling sequelae in erythroderma.
[FULL TEXT] [PDF]*
|
